Catherine M. Szyman - 15 Jun 2021 Form 4 Insider Report for Edwards Lifesciences Corp (EW)

Role: CVP, Critical Care
Signature: Linda J. Park, Attorney-in-Fact
Issuer symbol: EW
Transactions as of: 15 Jun 2021
Net transactions value: -$268,992
Form type: 4
Filing time: 15 Jun 2021, 20:33:30 UTC
Previous filing: 04 Jun 2021
Next filing: 02 Aug 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EW	Common Stock	Options Exercise	$75,998	+3,410	+12%	$22.29	31,115	15 Jun 2021	Direct	F1
transaction	EW	Common Stock	Sale	$344,990	-3,410	-11%	$101.17	27,705	15 Jun 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	EW	Employee Stock Option (Right to Acquire)	Options Exercise	$0	-3,410	-100%	$0.000000^*	0	15 Jun 2021	Common Stock	3,410	$22.29	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 24, 2020.

Remarks:

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.